Related Experiment Video

Updated: Jul 15, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

5.1K

Development of a Komagataella phaffii-based expression system for high-activity anti-SARS-CoV-2 neutralizing

Xueqin Liu1,2,3,4,5, Qiaoli Lang1,2,3,4,5, Nan Huang1,2,3,4,5

  • 1Chongqing Academy of Animal Sciences, Chongqing, China.

AMB Express
|December 11, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Komagataella phaffiiPichia pastorisAntibodyFermentation optimizationSARS-CoV-2scFv

More Related Videos

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.4K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.6K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...